Quanterix Corp (QTRX):企業の製品パイプライン分析2018

◆英語タイトル:Quanterix Corp (QTRX) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C2870
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Quanterix Corp (Quanterix) is a medical equipment provider that offers proteins measurement solutions. The company’s products include biomarker detection system, assay kits, single molecule detector and analyzers. It provides clinical sample and outsourced testing, custom assay development, assay feasibility testing and prototype development, assay optimization and assay validation through its innovative accelerator lab. Quanterix’s technologies are used in life sciences research, oncology, neurology, inflammatory disease and infectious disease areas. The company offers certificates for analysis that are conducted using its products. It partners with sports and healthcare sectors to detect symptoms and signs of injuries. Quanterix is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Quanterix Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Quanterix Corp Company Overview 5
Quanterix Corp Company Snapshot 5
Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Quanterix Corp – Pipeline Analysis Overview 8
Quanterix Corp – Key Facts 8
Quanterix Corp – Major Products and Services 9
Quanterix Corp Pipeline Products by Development Stage 10
Quanterix Corp Pipeline Products Overview 12
AccuPSA Test 12
AccuPSA Test Product Overview 12
Antigen Detection Assay – Tuberculosis 13
Antigen Detection Assay – Tuberculosis Product Overview 13
Blood Test – Concussions/TBI 14
Blood Test – Concussions/TBI Product Overview 14
Diagnostic Blood Test – Huntington’s Disease 15
Diagnostic Blood Test – Huntington’s Disease Product Overview 15
Digital ELISA – Crohn’s Disease 16
Digital ELISA – Crohn’s Disease Product Overview 16
Digital ELISA Assay – C. Difficile 17
Digital ELISA Assay – C. Difficile Product Overview 17
NeuroFilament Light Assay – Alzheimer’s Disease 18
NeuroFilament Light Assay – Alzheimer’s Disease Product Overview 18
POC Device – Neurological Injuries 19
POC Device – Neurological Injuries Product Overview 19
Simoa 3.0 20
Simoa 3.0 Product Overview 20
Simoa 4.0 21
Simoa 4.0 Product Overview 21
Simoa 5.0 22
Simoa 5.0 Product Overview 22
SiMoA HD-1 Analyzer – Botulinum Toxin Assay 23
SiMoA HD-1 Analyzer – Botulinum Toxin Assay Product Overview 23
Simoa HD-1 Analyzer – Lung Cancer 24
Simoa HD-1 Analyzer – Lung Cancer Product Overview 24
Simoa HD-1 Analyzer – Pancreatic Cancer 25
Simoa HD-1 Analyzer – Pancreatic Cancer Product Overview 25
SiMoA HD-1 Analyzer – Prostate Cancer Assay 26
SiMoA HD-1 Analyzer – Prostate Cancer Assay Product Overview 26
Quanterix Corp – Key Competitors 27
Quanterix Corp – Key Employees 28
Quanterix Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Quanterix Corp, Recent Developments 30
May 09, 2018: Quanterix Releases Operating Results for First Quarter 2018 30
Apr 27, 2018: Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone 30
Mar 14, 2018: Quanterix Releases Operating Results for Fourth Quarter and Fiscal Year 2017 31
Mar 08, 2018: New Research Demonstrates Enhanced Sensitivity for Acute HIV Detection Using Quanterix’ Simoa Technology 32
Jan 15, 2018: Quanterix Developing Biomarkers for Concussions 33
Jan 10, 2018: Quanterix: Results of Operations and Financial Condition 34
Nov 10, 2017: Quanterix to Showcase New SR-X Ultra-Sensitive Biomarker Detection System at Neuroscience 2017 34
Oct 17, 2017: Dr. David Walt of Wyss Institute to Speak at Powering Precision Health 2017 35
Sep 26, 2017: Aushon BioSystems and ABL Announce Adoption of the Cira Platform for Multiplex and Ultrasensitive Biomarker Testing 36
Sep 07, 2017: Quanterix To Host Webinar On Predicting The Progression Of Neurodegeneration With A Blood Test 36
Appendix 37
Methodology 37
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Quanterix Corp Pipeline Products by Equipment Type 6
Quanterix Corp Pipeline Products by Indication 7
Quanterix Corp, Key Facts 8
Quanterix Corp, Major Products and Services 9
Quanterix Corp Number of Pipeline Products by Development Stage 10
Quanterix Corp Pipeline Products Summary by Development Stage 11
AccuPSA Test - Product Status 12
AccuPSA Test - Product Description 12
Antigen Detection Assay - Tuberculosis - Product Status 13
Antigen Detection Assay - Tuberculosis - Product Description 13
Blood Test - Concussions/TBI - Product Status 14
Blood Test - Concussions/TBI - Product Description 14
Diagnostic Blood Test - Huntington’s Disease - Product Status 15
Diagnostic Blood Test - Huntington’s Disease - Product Description 15
Digital ELISA - Crohn’s Disease - Product Status 16
Digital ELISA - Crohn’s Disease - Product Description 16
Digital ELISA Assay - C. Difficile - Product Status 17
Digital ELISA Assay - C. Difficile - Product Description 17
NeuroFilament Light Assay - Alzheimer’s Disease - Product Status 18
NeuroFilament Light Assay - Alzheimer’s Disease - Product Description 18
POC Device - Neurological Injuries - Product Status 19
POC Device - Neurological Injuries - Product Description 19
Simoa 3.0 - Product Status 20
Simoa 3.0 - Product Description 20
Simoa 4.0 - Product Status 21
Simoa 4.0 - Product Description 21
Simoa 5.0 - Product Status 22
Simoa 5.0 - Product Description 22
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Status 23
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Description 23
Simoa HD-1 Analyzer - Lung Cancer - Product Status 24
Simoa HD-1 Analyzer - Lung Cancer - Product Description 24
Simoa HD-1 Analyzer - Pancreatic Cancer - Product Status 25
Simoa HD-1 Analyzer - Pancreatic Cancer - Product Description 25
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Status 26
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Description 26
Quanterix Corp, Key Employees 28
Quanterix Corp, Subsidiaries 29
Glossary 39

List of Figures
Quanterix Corp Pipeline Products by Equipment Type 6
Quanterix Corp Pipeline Products by Development Stage 10

★海外企業調査レポート[Quanterix Corp (QTRX):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Providence Health & Services-製薬・医療分野:企業M&A・提携分析
    Summary Providence Health & Services (Providence) is a not for profit organization which offers health care services to its communities in Alaska, Washington, Montana, Oregon and California. The organization operates hospitals and physician clinics, and, provides senior services, supportive housing …
  • Marfin Investment Group Holdings S.A.:企業のM&A・事業提携・投資動向
    Marfin Investment Group Holdings S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Marfin Investment Group Holdings S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • CollPlant Ltd (CLGN):医療機器:M&Aディール及び事業提携情報
    Summary CollPlant Holdings Ltd (CollPlant) is a regenerative medicine company that carries out development and commercialization of tissue repair products. The company offers orthobiologics, wound care, and pipeline products. Its orthobiologics products include VergenixSTR and VergenixBVF. CollPlant …
  • Allergan plc:企業の戦略・SWOT・財務情報
    Allergan plc - Strategy, SWOT and Corporate Finance Report Summary Allergan plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Mazagon Dock Shipbuilders Ltd:戦略・SWOT・企業財務分析
    Mazagon Dock Shipbuilders Ltd - Strategy, SWOT and Corporate Finance Report Summary Mazagon Dock Shipbuilders Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sprint Bioscience AB (SPRINT):企業の財務・戦略的SWOT分析
    Summary Sprint Bioscience AB (Sprint Bioscience) is a developer of pharmaceutical products in the areas of cancer and metabolism. The company develops STK25, a drug candidate against a new target protein for the treatment of type 2 diabetes; VPS34, a drug candidate for the treatment of various types …
  • Cranswick Plc
    Cranswick Plc - Strategy, SWOT and Corporate Finance Report Summary Cranswick Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Evertec Inc (EVTC):企業の財務・戦略的SWOT分析
    Summary Evertec Inc (Evertec) is a technology and communication company that offers transaction processing services. The company’s services include payment processing, merchant acquiring and business process management. Its payment processing services comprise card issuing and acquiring processing; …
  • Bluestar Adisseo Co (600299):企業の財務・戦略的SWOT分析
    Summary Bluestar Adisseo Co (Bluestar Adisseo), a subsidiary of China National BlueStar (Group) Co Ltd, is a chemical company that offers research, development, production and sales of feed additives. The company offers functional products, special products and others. It provides methionine product …
  • Netalogue Technologies plc (NTLP):企業の財務・戦略的SWOT分析
    Summary Netalogue Technologies plc (Netalogue) is a technology company that develops, markets and support e-procurement software systems. The company offers services such as e-commerce solutions, web design, hosting and e-marketing. It solutions include B2B Webstores, B2B/C webstores, B2corp, B2chan …
  • ITT Inc.:企業の戦略・SWOT・財務情報
    ITT Inc. - Strategy, SWOT and Corporate Finance Report Summary ITT Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • MGB Biopharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary MGB Biopharma Ltd (MGB) is a clinical stage biopharmaceutical company which develops anti-infective medicine of minor groove binder (MGBs) compounds. The company focuses on the development of new class of small molecules, with specific antibacterial activity against susceptible and resistant …
  • Greif, Inc.:企業の戦略・SWOT・財務分析
    Greif, Inc. - Strategy, SWOT and Corporate Finance Report Summary Greif, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Heidelberg Pharma AG (WL6):製薬・医療:M&Aディール及び事業提携情報
    Summary Heidelberg Pharma AG (Heidelberg Pharma) formerly, Wilex AG is a biopharmaceutical company. The company develops therapeutic and diagnostic product candidates for the treatment and specific detection of various cancers. Heidelberg Pharma’s pipeline products are focused on treating multiple m …
  • Credit Saison Co., Ltd.
    Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PFSweb Inc (PFSW):企業の財務・戦略的SWOT分析
    Summary PFSweb Inc (PFSweb) is an eCommerce solutions provider. Its various services include agency services, marketing services, technology and financial services. The company offers solutions for omnichannel operations, technology ecosystem, and strategic commerce consulting. Its technology ecosys …
  • Ingenico SA (ING):企業の財務・戦略的SWOT分析
    Ingenico SA (ING) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Entellus Medical Inc (ENTL):企業の財務・戦略的SWOT分析
    Summary Entellus Medical Inc (Entellus Medical) a subsidiary of Stryker Corp, operates as a medical device company that offers invasive products for the treatment of chronic sinusitis. The company’s products include multi sinus dilation system, surgical instruments, sinonasal suction and irrigation …
  • Valeura Energy Inc (VLE):企業の財務・戦略的SWOT分析
    Valeura Energy Inc (VLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Impax Laboratories Inc (IPXL)-製薬・医療分野:企業M&A・提携分析
    Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous sy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆